◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

阳普医疗

阳普医疗
Loading...
Key Metrics
Market Cap
2.4B ($344.0M)
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
581.0M
Net Income
-120.0M
Gross Margin
N/A
Op. Margin
-20.1%
Net Margin
-20.7%
ROE
-18.6%
ROA
-9.6%
D/E
0.93
Dividend Yield
N/A
EPS
-0.38
Current Ratio
1.15
Price History
Company Info
IndustryC35专用设备制造业
Market SegmentChiNext
CurrencyCNY
Fiscal Year2024
Business Overview

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and d...

Peers
工商银行
601398
2.7T
P/E: 7.6
建设银行
601939
2.5T
P/E: 7.2
农业银行
601288
2.4T
P/E: 8.7
中国海油
600938
2.0T
P/E: 16.2
宁德时代
300750
1.9T
P/E: 25.6
贵州茅台
600519
1.8T
P/E: 20.1
中国银行
601988
1.8T
P/E: 7.3
中国人寿
601628
1.2T
P/E: 6.9
Financial Statements
Loading financials...
Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 阳普医疗

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and disposable tourniquets, urine collection systems, and holders under IMPROVACUTER brand name; and IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, IMPROSAFE safety blood collection needles, IMPROSWAB microbiological transport swabs, IMPROVE sharps containers, liquid biopsy pre-analytical systems, etc. In addition, it provides clinical nursing products, including automatic, handheld, pulsewave, and smart wireless blood pressure monitors; and intelligent management solutions, such as blood collection tube preparation systems, friendly graphic user interfaces, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels, as well as CryoMax vials and liquid nitrogen freezing storage boxes. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. and changed its name to Improve Medical Instruments Co., Ltd. in December 2021. The company was founded in 1996 and is headquartered in Guangzhou, China.


Ticker300030
ExchangeSZSE
Sector证监会行业分类
IndustryC35专用设备制造业
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...